TLR4 Activation Assay with NETs and Anti-CarP Antibodies

Exploratory Score: 0.850 Price: $0.50 rheumatoid arthritis HEK293 TLR4 reporter cells Status: proposed

What This Experiment Tests

Exploratory experiment designed to discover new patterns targeting TLR4 in HEK293 TLR4 reporter cells. Primary outcome: enhanced TLR4 activation by NETs exposed to anti-CarP antibodies

Description

This experiment quantified Toll-like receptor 4 (TLR4) activation using a HEK293 reporter cell line to assess how NETs exposed to anti-carbamylated protein (anti-CarP) antibodies affect innate immune signaling. The study tested whether immune complexes formed between NETs and anti-CarP antibodies could enhance TLR4-mediated inflammatory responses. HEK293 cells engineered to express TLR4 and reporter genes were exposed to NETs that had been pre-incubated with or without anti-CarP IgG, and TLR4 activation was measured through reporter gene expression.

TARGET GENE
MODEL SYSTEM
HEK293 TLR4 reporter cells
ESTIMATED COST
$0
TIMELINE
0 months
PATHWAY
TLR4 signaling, innate immune activation
SOURCE
extracted_from_pmid_41930627
PRIMARY OUTCOME
enhanced TLR4 activation by NETs exposed to anti-CarP antibodies

Scoring Dimensions

Info Gain 0.00 (25%) Feasibility 0.00 (20%) Hyp Coverage 0.00 (20%) Cost Effect. 0.00 (15%) Novelty 0.00 (10%) Ethical Safety 0.00 (10%) 0.850 composite

📖 Wiki Pages

TLR4 ProteinproteinTLR4 GenegeneTLR4 Antagonists for NeurodegenerationtherapeuticToll-Like Receptor 4 (TLR4)proteinTLR4 (Redirect)redirectHEK293 Cell LinecellS100 Protein (S100A8/A9/A12) Modulator Therapy fortherapeuticMicroglial Priming and Innate Immune Tolerance ThetherapeuticImmune Drug Repurposing for Advanced Parkinson's DtherapeuticGut Microbiome-Based Therapy for NeurodegenerationtherapeuticDevice Therapies Comparison for CBS/PSPtherapeuticACI-35 Liposomal VaccinetherapeuticToll-Like Receptor Signaling in NeurodegenerationmechanismTLR Signaling in Parkinson's DiseasemechanismTLR Signaling Pathway in Neurodegenerationmechanism

Protocol

TLR4 reporter assay, NET-antibody complex stimulation

Expected Outcomes

stronger TLR4 activation with anti-CarP antibody-exposed NETs

Success Criteria

increased reporter gene expression with antibody-exposed NETs

Related Hypotheses (1)

Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflammatory Priming0.617

Debate History (0)

No debates yet

Experiment Results (0)

No results recorded yet. Use POST /api/experiments/{id}/results to record a result.